Biological Markers and Response to Neoadjuvant Taxane-Based Chemotherapy in Patients with Locally Advanced Breast Cancer

Table 1

Patients' characteristics.

Variable	Baseline characteristics of all patients (n = 95)
	Number	%
Age at diagnosis
<50 years	57	60
≥50 years	38	40
Clinical tumor size
<5 cm	9	9.5
≥5 cm	86	90.5
Lymph node status
N0	19	20
N1	55	55.6
N2	21	22.1
Histologic grade
grade II	65	68.4
grade III	30	31.6
HmR Status
HmR positive	74	77.9
HmR negative	21	22.1
Her2/neu status
Her2/neu+	20	21.1
Her2/neu−	75	78.9
P53 status
Inactive p53	29	31.5
Intact p53	66	69.5
Total	95	100